Peptides & Building Blocks

Fmoc-D-Thiazolidine-4-Carboxylic Acid

  • CAS No.198545-89-0
  • GradeIndustrial / Pharmaceutical
  • Availability● In Stock

High-purity Fmoc-D-Thiazolidine-4-Carboxylic Acid designed for advanced peptide synthesis applications. Available in bulk quantities with full documentation.

Request a Quote & Full COA

Product Technical Details

Product Overview

Fmoc-D-Thiazolidine-4-Carboxylic Acid represents a highly specialized protected amino acid derivative designed for advanced pharmaceutical research and peptide synthesis applications. As a critical building block, this compound features a fluorenylmethyloxycarbonyl (Fmoc) protecting group attached to the D-enantiomer of thiazolidine-4-carboxylic acid. This specific configuration ensures optimal stability during solid-phase peptide synthesis (SPPS) while preventing racemization, a common challenge in complex molecule assembly. Our manufacturing process adheres to strict quality control standards, ensuring that every batch meets the rigorous demands of modern drug discovery and development pipelines.

The compound is supplied as a white crystalline powder, indicating high levels of purity and consistency essential for reproducible experimental results. By utilizing this specific chiral building block, chemists can introduce unique structural constraints into peptide chains, potentially enhancing the biological activity and metabolic stability of the final therapeutic agent. We are committed to supplying reliable materials that support innovation in medicinal chemistry.

Technical Specifications

ParameterValue
CAS Number198545-89-0
Molecular FormulaC19H17NO4S
Molecular Weight355.41 g/mol
Purity≥98%
AppearanceWhite Crystalline Powder
Density1.402±0.06 g/cm3

Industrial Applications

This chemical serves as a fundamental intermediate in the synthesis of bioactive peptides and peptidomimetics. The thiazolidine ring structure offers unique conformational constraints that can enhance the biological activity and metabolic stability of the final peptide therapeutic. Researchers utilize this building block extensively in the development of novel pharmaceutical agents targeting various physiological pathways. The Fmoc protection strategy allows for orthogonal deprotection conditions, making it compatible with a wide range of synthesis protocols.

  • Solid-phase peptide synthesis (SPPS)
  • Development of protease inhibitors
  • Structure-activity relationship (SAR) studies
  • Production of specialized peptide libraries
  • Pharmaceutical intermediate manufacturing

Quality Assurance and Storage

We prioritize product integrity throughout the supply chain. Each shipment is accompanied by a Certificate of Analysis (COA) verifying identity, purity, and physical properties. To maintain stability, the material should be stored in tightly closed containers within a cool, dry environment, protected from moisture and direct light. Proper handling ensures the longevity of the Fmoc protecting group, preventing premature deprotection which could compromise synthesis efficiency. Our global logistics network supports bulk orders with flexible packaging options, including 25 kg drums or customized solutions based on specific client requirements. We are committed to providing reliable supply chains for pharmaceutical manufacturers and research institutions worldwide.